In Gian Kaur (1996), the Supreme Court explicitly ruled that the 'right to die' is not included in Article 21. The Common Cause judgment (2018), however, clarified and expanded Article 21 to include the 'right to die with dignity' by allowing passive euthanasia. The critical distinction for MCQs is that Gian Kaur rejected the 'right to die', while Common Cause recognized a specific facet: the 'right to die with dignity' through passive means. This shows a jurisprudential shift, often tested in chronological or comparative statements.

Prior to the Common Cause judgment, India lacked a clear legal framework for withdrawing life support for terminally ill patients or those in a Persistent Vegetative State (PVS). This created a dilemma for families and doctors, who often faced legal ambiguity and ethical conflicts when deciding to cease futile treatment. The absence of 'living wills' meant individuals had no legal way to express their end-of-life wishes in advance, leading to prolonged suffering and emotional distress for all involved. The judgment provided a much-needed legal pathway and clarity.

The Harish Rana case was significant because it was the first time the Supreme Court allowed the withdrawal of life support under the Common Cause framework. Crucially, the Court clarified that Clinically Assisted Nutrition and Hydration (CANH) – essentially feeding tubes and IV fluids – should be considered 'medical treatment' and not just basic sustenance. This clarification is vital because it means CANH can also be withdrawn under the passive euthanasia guidelines, allowing for a more complete cessation of life-sustaining measures when appropriate.

If a patient has not made a 'living will', the process for passive euthanasia becomes more elaborate and involves multiple layers of medical and judicial review to ensure the decision is in the patient's best interest and free from coercion.

• •Primary Medical Board: An initial board of doctors (at least 5 years experience) at the treating hospital certifies the patient's irreversible condition.
• •Secondary Medical Board: A second, independent board (including an external specialist, also with 5+ years experience) reviews and concurs with the primary board's findings.
• •JMFC Notification: Post-2023, the hospital only needs to inform the JMFC of the decision to withdraw treatment, rather than seeking prior approval.

The Aruna Shanbaug case was pivotal. While the Supreme Court ultimately denied the petition to end her life, it recognized the concept of passive euthanasia and laid down detailed guidelines for its potential application in future cases. This judgment, for the first time, opened the judicial door to considering the withdrawal of life support for patients in a Persistent Vegetative State (PVS) and established the need for high court approval and medical board reviews. It created a precedent and a procedural framework that the Common Cause judgment later built upon and refined, moving from a case-by-case approach to a more generalized legal right.

This 'slippery slope' argument is a significant ethical concern.

• •Robust Safeguards: The Common Cause judgment includes stringent safeguards like multiple medical board reviews, judicial oversight (even if simplified post-2023), and the requirement for a clear 'living will' or family consensus. These are designed to prevent misuse and coercion.
• •Distinction between Passive and Active: It's crucial to reiterate that the judgment strictly differentiates passive euthanasia (allowing natural death by withdrawing treatment) from active euthanasia (intentionally ending life). The legal framework only permits the former.
• •Individual Autonomy vs. State Interest: While the state has an interest in protecting all life, respecting an individual's right to self-determination and dignity in death, especially when facing irreversible suffering, is also a fundamental value. The judgment seeks to balance these by providing a dignified exit without endorsing a 'right to kill'.
• •Continuous Review: The framework is not static. The 2023 amendments show the Supreme Court's willingness to review and refine the process, suggesting that any emerging 'slippery slope' concerns can be addressed through further judicial or legislative intervention.

India's framework is relatively conservative compared to some Western democracies but progressive within the Asian context.

• •Comparison: Many European countries (e.g., Netherlands, Belgium) allow active euthanasia or physician-assisted suicide under strict conditions, which India explicitly prohibits. Countries like the UK and Canada have legalized physician-assisted dying, but India's focus is solely on passive euthanasia. However, India's recognition of 'living wills' aligns with practices in several countries like the US and Australia.
• •Lessons for India: India can learn from other nations' experiences regarding the practical implementation of 'living wills', public awareness campaigns, and training for medical professionals to handle end-of-life decisions. The challenge in India is ensuring these complex legal provisions are understood and accessible across diverse socio-economic strata, especially in rural areas, which is less of an issue in countries with robust healthcare and legal literacy.
• •India's Strength: India's framework emphasizes robust judicial oversight and multiple medical opinions, which provides strong safeguards against potential misuse, a concern often debated in countries with more liberal euthanasia laws.

While the 2023 amendments simplified the process, further steps could enhance implementation.

• •Legislative Codification: The judgment is based on judicial pronouncements. A dedicated law passed by Parliament could provide greater clarity, permanence, and public legitimacy, moving it beyond the realm of judicial guidelines. This would also allow for more detailed procedural rules and penalties for misuse.
• •Public Awareness Campaigns: Many citizens are still unaware of 'living wills' or the process of passive euthanasia. Extensive public awareness campaigns, especially in regional languages, are crucial to empower individuals to make informed choices.
• •Training for Medical Professionals: Doctors and hospital staff need comprehensive training on the legal nuances and ethical considerations of the judgment, including the updated JMFC role and the formation of medical boards, to ensure smooth and compliant implementation.
• •Standardized Forms: Developing standardized, easy-to-understand forms for 'living wills' and associated documentation could reduce errors and streamline the process for both citizens and medical institutions.

Despite its progressive nature, the Common Cause judgment faces several criticisms and implementation challenges.

• •Awareness and Accessibility: A major gap is the lack of widespread public awareness about 'living wills' and the passive euthanasia process, especially in rural and less educated populations. This limits its practical utility.
• •Medical Board Burden: Even with simplifications, forming multiple medical boards and ensuring their independence and expertise can be a logistical challenge, especially in smaller hospitals or remote areas.
• •Ethical Dilemmas for Doctors: Doctors may still face ethical conflicts or fear legal repercussions, even with the judgment, leading to reluctance in implementing passive euthanasia.
• •Potential for Misuse (Inheritance/Family Disputes): While safeguards exist, critics worry about the potential for family members to pressure a patient or manipulate the process for personal gain, especially if a 'living will' is not in place.
• •Definition of 'Terminal Illness'/'PVS': While defined, the interpretation can sometimes be subjective, leading to disputes or delays in decision-making.

Prelims questions often focus on the composition and distinct roles of these boards.

• •Primary Medical Board: Formed by the treating hospital, it comprises doctors with at least five years of experience. Its role is to initially examine the patient and certify that there is no hope of recovery.
• •Secondary Medical Board: This board is formed subsequently and includes an external specialist (not from the treating hospital) along with other doctors, all having at least five years of experience. Its key role is to independently review and concur with the findings of the Primary Medical Board, adding an extra layer of scrutiny.
• •Key Difference: The Primary Board makes the initial assessment, while the Secondary Board provides an independent, confirmatory review, often with an external expert to ensure impartiality.

In Gian Kaur (1996), the Supreme Court explicitly ruled that the 'right to die' is not included in Article 21. The Common Cause judgment (2018), however, clarified and expanded Article 21 to include the 'right to die with dignity' by allowing passive euthanasia. The critical distinction for MCQs is that Gian Kaur rejected the 'right to die', while Common Cause recognized a specific facet: the 'right to die with dignity' through passive means. This shows a jurisprudential shift, often tested in chronological or comparative statements.

Prior to the Common Cause judgment, India lacked a clear legal framework for withdrawing life support for terminally ill patients or those in a Persistent Vegetative State (PVS). This created a dilemma for families and doctors, who often faced legal ambiguity and ethical conflicts when deciding to cease futile treatment. The absence of 'living wills' meant individuals had no legal way to express their end-of-life wishes in advance, leading to prolonged suffering and emotional distress for all involved. The judgment provided a much-needed legal pathway and clarity.

The Harish Rana case was significant because it was the first time the Supreme Court allowed the withdrawal of life support under the Common Cause framework. Crucially, the Court clarified that Clinically Assisted Nutrition and Hydration (CANH) – essentially feeding tubes and IV fluids – should be considered 'medical treatment' and not just basic sustenance. This clarification is vital because it means CANH can also be withdrawn under the passive euthanasia guidelines, allowing for a more complete cessation of life-sustaining measures when appropriate.

If a patient has not made a 'living will', the process for passive euthanasia becomes more elaborate and involves multiple layers of medical and judicial review to ensure the decision is in the patient's best interest and free from coercion.

• •Primary Medical Board: An initial board of doctors (at least 5 years experience) at the treating hospital certifies the patient's irreversible condition.
• •Secondary Medical Board: A second, independent board (including an external specialist, also with 5+ years experience) reviews and concurs with the primary board's findings.
• •JMFC Notification: Post-2023, the hospital only needs to inform the JMFC of the decision to withdraw treatment, rather than seeking prior approval.

The Aruna Shanbaug case was pivotal. While the Supreme Court ultimately denied the petition to end her life, it recognized the concept of passive euthanasia and laid down detailed guidelines for its potential application in future cases. This judgment, for the first time, opened the judicial door to considering the withdrawal of life support for patients in a Persistent Vegetative State (PVS) and established the need for high court approval and medical board reviews. It created a precedent and a procedural framework that the Common Cause judgment later built upon and refined, moving from a case-by-case approach to a more generalized legal right.

This 'slippery slope' argument is a significant ethical concern.

• •Robust Safeguards: The Common Cause judgment includes stringent safeguards like multiple medical board reviews, judicial oversight (even if simplified post-2023), and the requirement for a clear 'living will' or family consensus. These are designed to prevent misuse and coercion.
• •Distinction between Passive and Active: It's crucial to reiterate that the judgment strictly differentiates passive euthanasia (allowing natural death by withdrawing treatment) from active euthanasia (intentionally ending life). The legal framework only permits the former.
• •Individual Autonomy vs. State Interest: While the state has an interest in protecting all life, respecting an individual's right to self-determination and dignity in death, especially when facing irreversible suffering, is also a fundamental value. The judgment seeks to balance these by providing a dignified exit without endorsing a 'right to kill'.
• •Continuous Review: The framework is not static. The 2023 amendments show the Supreme Court's willingness to review and refine the process, suggesting that any emerging 'slippery slope' concerns can be addressed through further judicial or legislative intervention.

India's framework is relatively conservative compared to some Western democracies but progressive within the Asian context.

• •Comparison: Many European countries (e.g., Netherlands, Belgium) allow active euthanasia or physician-assisted suicide under strict conditions, which India explicitly prohibits. Countries like the UK and Canada have legalized physician-assisted dying, but India's focus is solely on passive euthanasia. However, India's recognition of 'living wills' aligns with practices in several countries like the US and Australia.
• •Lessons for India: India can learn from other nations' experiences regarding the practical implementation of 'living wills', public awareness campaigns, and training for medical professionals to handle end-of-life decisions. The challenge in India is ensuring these complex legal provisions are understood and accessible across diverse socio-economic strata, especially in rural areas, which is less of an issue in countries with robust healthcare and legal literacy.
• •India's Strength: India's framework emphasizes robust judicial oversight and multiple medical opinions, which provides strong safeguards against potential misuse, a concern often debated in countries with more liberal euthanasia laws.

While the 2023 amendments simplified the process, further steps could enhance implementation.

• •Legislative Codification: The judgment is based on judicial pronouncements. A dedicated law passed by Parliament could provide greater clarity, permanence, and public legitimacy, moving it beyond the realm of judicial guidelines. This would also allow for more detailed procedural rules and penalties for misuse.
• •Public Awareness Campaigns: Many citizens are still unaware of 'living wills' or the process of passive euthanasia. Extensive public awareness campaigns, especially in regional languages, are crucial to empower individuals to make informed choices.
• •Training for Medical Professionals: Doctors and hospital staff need comprehensive training on the legal nuances and ethical considerations of the judgment, including the updated JMFC role and the formation of medical boards, to ensure smooth and compliant implementation.
• •Standardized Forms: Developing standardized, easy-to-understand forms for 'living wills' and associated documentation could reduce errors and streamline the process for both citizens and medical institutions.

Despite its progressive nature, the Common Cause judgment faces several criticisms and implementation challenges.

• •Awareness and Accessibility: A major gap is the lack of widespread public awareness about 'living wills' and the passive euthanasia process, especially in rural and less educated populations. This limits its practical utility.
• •Medical Board Burden: Even with simplifications, forming multiple medical boards and ensuring their independence and expertise can be a logistical challenge, especially in smaller hospitals or remote areas.
• •Ethical Dilemmas for Doctors: Doctors may still face ethical conflicts or fear legal repercussions, even with the judgment, leading to reluctance in implementing passive euthanasia.
• •Potential for Misuse (Inheritance/Family Disputes): While safeguards exist, critics worry about the potential for family members to pressure a patient or manipulate the process for personal gain, especially if a 'living will' is not in place.
• •Definition of 'Terminal Illness'/'PVS': While defined, the interpretation can sometimes be subjective, leading to disputes or delays in decision-making.

Prelims questions often focus on the composition and distinct roles of these boards.

• •Primary Medical Board: Formed by the treating hospital, it comprises doctors with at least five years of experience. Its role is to initially examine the patient and certify that there is no hope of recovery.
• •Secondary Medical Board: This board is formed subsequently and includes an external specialist (not from the treating hospital) along with other doctors, all having at least five years of experience. Its key role is to independently review and concur with the findings of the Primary Medical Board, adding an extra layer of scrutiny.
• •Key Difference: The Primary Board makes the initial assessment, while the Secondary Board provides an independent, confirmatory review, often with an external expert to ensure impartiality.